Literature DB >> 16357695

The lung in systemic sclerosis.

Virginia D Steen1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16357695     DOI： 10.1097/01.rhu.0000152147.38706.db

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  15 in total

1.  Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.

Authors:  Sangmee Bae; Rajeev Saggar; Marcy B Bolster; Lorinda Chung; Mary Ellen Csuka; Chris Derk; Robyn Domsic; Aryeh Fischer; Tracy Frech; Avram Goldberg; Monique Hinchcliff; Vivien Hsu; Laura Hummers; Elena Schiopu; Maureen D Mayes; Vallerie McLaughlin; Jerry Molitor; Nausheen Naz; Daniel E Furst; Paul Maranian; Virginia Steen; Dinesh Khanna
Journal:  Ann Rheum Dis       Date:  2012-02-02       Impact factor: 19.103

2.  Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Authors:  Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

Review 3.  The promising role of lung ultrasound in systemic sclerosis.

Authors:  A Delle Sedie; L Carli; E Cioffi; S Bombardieri; L Riente
Journal:  Clin Rheumatol       Date:  2012-07-29       Impact factor: 2.980

4.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

5.  Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.

Authors:  Robert K McCall; James G Ravenel; Paul J Nietert; Aleksandra Granath; Richard M Silver
Journal:  J Comput Assist Tomogr       Date:  2014 Mar-Apr       Impact factor: 1.826

Review 6.  Diagnosis and management of pulmonary hypertension in systemic sclerosis.

Authors:  Nadera J Sweiss; Linda Hushaw; Thenappan Thenappan; Ray Sawaqed; Roberto F Machado; Amit R Patel; Mardi Gomberg-Maitland; Aliya N Husain; Stephen L Archer
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

7.  Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Christina A Meadows; Michael G Risbano; Li Zhang; Mark W Geraci; Rubin M Tuder; David H Collier; Todd M Bull
Journal:  Chest       Date:  2010-09-09       Impact factor: 9.410

Review 8.  [Systemic sclerosis. Objectives for the treatment].

Authors:  B Maurer; M Walder; R E Gay; S Gay; O Distler
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 9.  Scleroderma lung: pathogenesis, evaluation and current therapy.

Authors:  Jacob M van Laar; Jan Stolk; Alan Tyndall
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.

Authors:  Marie Hudson; Deborah Assayag; Melissa Caron; Benjamin D Fox; Andrew Hirsch; Russell Steele; Rebecca Gaudreau-Taillefer; Solène Tatibouet; Lawrence Rudski; Murray Baron
Journal:  Clin Rheumatol       Date:  2013-06-04       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.